B. Stein

2.2k citations

27 papers · 1.4k indexed · 1 hit paper · h-index 13

Impact in

Orthopedics and Sports Medicine top 1%
- Bone and Joint Diseases
Otorhinolaryngology top 2%
- Head and Neck Cancer Studies

Papers in ⓘ

Oncology 16
- CAR-T cell therapy research 5
- Bone health and treatments 4
- Cancer Immunotherapy and Biomarkers 3
Pulmonary and Respiratory Medicine 8

Co-authors: Alastair N. Goss (6 shared papers)Andrew Cheng (3 shared papers)Deborah L. Driscoll (1 shared paper)Neal J. Meropol (1 shared paper)Harold O. Douglass (1 shared paper)Giuseppina Arcangeli (1 shared paper)Nicholas J. Petrelli (1 shared paper)A. Cheng (3 shared papers)
Journals: Journal of Clinical Oncology (4 papers)Journal of Oral and Maxillofacial Surgery (3 papers)Annals of Oncology (2 papers)Australian Dental Journal (2 papers)Cancer Research (2 papers)
Partner nations: Australia United States Belgium

In The Last Decade

B. Stein

24 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial 2013 · 314 citations

Peers

Countries citing papers authored by B. Stein

Since Specialization

Citations

This map shows the geographic impact of B. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Stein more than expected).

Fields of papers citing papers by B. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Stein. The network helps show where B. Stein may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Stein Line = papers co-authored together B. Stein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia Journal of Oral and Maxillofacial Surgery ·Tony Mavrokokki, Andrew Cheng, B. Stein, Alastair N. Goss	2007	489
2	Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial The Lancet Oncology ·Jan B. Vermorken, Jan Stöhlmacher-Williams, Ірина Давиденко, Lisa Licitra, Eric Winquist, Cristian Villanueva, Paolo Foa, Sylvie Rottey, Krzysztof Składowski, Makoto Tahara, Vasant R. Pai, Sandrine Faivre, C. Blajman, Arlene A. Forastiere, B. Stein, Kelly S. Oliner, Zhiying Pan, Bruce Allen Bach Hit paper breakdown →	2013	314
3	Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial Cancer ·B. Stein, Nicholas J. Petrelli, Harold O. Douglass, Deborah L. Driscoll, Giuseppina Arcangeli, Neal J. Meropol	1995	213
4	The dental implications of bisphosphonates and bone disease Australian Dental Journal ·A. Cheng, A. Mavrokokki, G. Carter, B. Stein, NL Fazzalari, DF Wilson, Alastair N. Goss	2005	104
5	Stat6 Activation Is Essential for Interleukin-4 Induction of P-Selectin Transcription in Human Umbilical Vein Endothelial Cells Arteriosclerosis Thrombosis and Vascular Biology ·Yeesim Khew‐Goodall, Carol Wadham, B. Stein, Jennifer R. Gamble, Mathew A. Vadas	1999	48
6	Alveolar bone and the bisphosphonates Australian Dental Journal ·A. Cheng, CG Daly, RM Logan, B. Stein, Alastair N. Goss	2009	32
7	A C-Terminal Crosslinking Telopeptide Test–Based Protocol for Patients on Oral Bisphosphonates Requiring Extraction: A Prospective Single-Center Controlled Study Journal of Oral and Maxillofacial Surgery ·A. C. J. Hutcheson, Andrew Cheng, Ranjit Kunchar, B. Stein, Paul Sambrook, Alastair N. Goss	2014	30
8	Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force Critical Reviews in Oncology/Hematology ·S. Monfardini, Matti Aapro, John M. Bennett, Mayumi Mori, Donna I. Regenstreif, Miriam Rodin, B. Stein, Gilbert B. Zulian, Jean‐Pierre Droz	2007	27
9	Postoperative Bleeding Following Dental Extractions in Patients Anticoagulated With Warfarin Journal of Oral and Maxillofacial Surgery ·Anthony Febbo, Andrew Cheng, B. Stein, Alastair N. Goss, Paul Sambrook	2016	24
10	Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying Internal Medicine Journal ·Christos S. Karapetis, B. Stein, Bogda Koczwara, Rosemary Harrup, Linda Milleshkin, Phil Parente, Michael Millward, Ian Haines, Prunella Blinman, Ian Olver	2018	23
11	Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes Journal of Immunological Methods ·K. Van Camp, Nathalie Cools, B. Stein, Ann Van de Velde, Herman Goossens, Zwi Berneman, Viggo Van Tendeloo	2010	23
12	Activation of Endothelial Extracellular Signal-Regulated Kinase Is Essential for Neutrophil Transmigration: Potential Involvement of a Soluble Neutrophil Factor in Endothelial Activation The Journal of Immunology ·B. Stein, Jennifer R. Gamble, Stuart M. Pitson, Mathew A. Vadas, Yeesim Khew‐Goodall	2003	23
13	Immunotherapy and other systemic therapies for cutaneous SCC Oral Oncology ·Alexander Guminski, B. Stein	2019	17
14	Abstract CT508: Safety and efficacy of vibostolimab (vibo) plus pembrolizumab (pembro) in patients (pts) with cervical cancer naive to PD-1/PD-L1 inhibitors Cancer Research ·Ronnie Shapira‐Frommer, Ruth Perets, Mark Voskoboynik, Kathryn F. Mileham, Adnan Nagrial, B. Stein, Vincent Chung, Martin Gutierrez, Diana Chen, T. Keenan, Mohini Rajasagi, Jane Healy, Sun Young Rha	2022	8
15	Vaccination of cancer patients with dendritic cells electroporated with mRNA encoding the wilms' tumor 1 protein (WT1): correlation of clinical effect and overall survival with T-cell response Cytotherapy ·Zwi Berneman, Sébastien Anguille, Yannick Willemen, Ann Van de Velde, Paul Germonpré, Manon Huizing, Viggo Van Tendeloo, Kirsten Saevels, L. Rutsaert, Katrien Vermeulen, Annemiek Snoeckx, Bart Op de Beeck, Nathalie Cools, Griet Nijs, B. Stein, Eva Lion, Ann Van Driessche, Marc Peeters, Elke Smits	2019	7
16	Effects of a prescribed, supervised exercise programme on tumour disease progression in oncology patients undergoing anti‐cancer therapy: a retrospective observational cohort study Internal Medicine Journal ·Georgia Salamon, Daniella Dougherty, Lauren Whiting, Gregory B. Crawford, B. Stein, Dusan Kotasek	2020	5
17	Double-blind, placebo-controlled trial of toremifene for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia Journal of Clinical Oncology ·David T. Price, B. Stein, Eric T. Goluboff, Paul Sieber, David G. Bostwick, Gary Barnette, R. Boger, M. S. Steiner	2005	5
18	Efficacy of erlotinib in patients with advanced Non‐small‐cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study Asia-Pacific Journal of Clinical Oncology ·Michael Boyer, Keith Horwood, Nick Pavlakis, Paul de Souza, Michael Millward, B. Stein, Michael Johnston, F. Abell, Danny Rischin	2012	4
19	1846P Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer Annals of Oncology ·Daniel Osei-Fofie, G. Landers, Julie Wetter, Petra Kraus, Shawgi Sukumaran, Mun Hui, B. Stein, Victoria Bray, Carol A. Connell, Bomi Framroze, J. Gelfand, A. Lategan, Paul Y. Song, Mikaela Dimitriu, Stephen T. Sonis	2020	2
20	818P Phase II confirmatory study of cemiplimab (350mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6 Annals of Oncology ·B.G.M. Hughes, Jean‐Jacques Grob, Samantha Bowyer, Fiona Day, Rahul Ladwa, B. Stein, (unknown), Nicole Basset‐Séguin, Alexander Guminski, Laurent Mortier, A. Hauschild, M.R. Migden, Chrysalyne D. Schmults, S-Y. Yoo, Jocelyn Booth, Frank Seebach, I. Lowy, M.G. Fury, Danny Rischin	2022	2

About B. Stein

B. Stein is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Orthopedics and Sports Medicine and Immunology, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Bone health and treatments (4 papers), Bone and Joint Diseases (4 papers), Head and Neck Cancer Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nonmelanoma Skin Cancer Studies (3 papers), Economic and Financial Impacts of Cancer (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (524 citations), Otorhinolaryngology (208 citations), Oncology (1.1k citations), Geriatrics and Gerontology (47 citations) and Rheumatology (161 citations). B. Stein has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include Alastair N. Goss, Andrew Cheng, Deborah L. Driscoll, Neal J. Meropol, Harold O. Douglass, Giuseppina Arcangeli, Nicholas J. Petrelli, A. Cheng, Bruce Allen Bach and Sandrine Faivre. Their work appears in journals such as Journal of Clinical Oncology, Journal of Oral and Maxillofacial Surgery, Annals of Oncology, Australian Dental Journal and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact